SXR3:F:F-iShares VII Public Limited Company - iShares MSCI UK UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 167.3

Change

0.00 (0.00)%

Market Cap

USD 0.09B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.11 (+2.43%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.95 (+1.90%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.29 (+2.15%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.23%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+5.65 (+2.74%)

USD 45.80B
0ZC:F Zscaler Inc

+0.02 (+0.01%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.68 (+0.59%)

USD 24.77B

ETFs Containing SXR3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.47% 61% D- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.47% 61% D- 64% D
Trailing 12 Months  
Capital Gain 2.66% 78% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.66% 75% C 60% D-
Trailing 5 Years  
Capital Gain 66.40% 72% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.40% 72% C 51% F
Average Annual (5 Year Horizon)  
Capital Gain 13.54% 81% B- 72% C
Dividend Return 13.54% 78% C+ 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.30% 70% C- 92% A
Risk Adjusted Return 145.56% 99% N/A 99% N/A
Market Capitalization 0.09B 28% F 29% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.